Key facts
- Heal Fertility can resume all 17 licensed treatment services from Tuesday, October 6, 2026.
Heal Fertility in Hong Kong has been cleared to resume all 17 licensed treatment services starting Tuesday, October 6, 2026. The Council on Human Reproductive Technology approved the resumption after confirming the clinic implemented remedial measures following an embryo specimen mix-up.

The resumption of services at Heal Fertility ensures continued access to assisted reproductive technologies for patients in Hong Kong, following a period of disruption caused by a serious procedural error.
Heal Fertility, a fertility clinic in Hong Kong, has been cleared by the Council on Human Reproductive Technology to fully resume all 17 of its licensed treatment services starting Tuesday, October 6, 2026. The clinic had most of its services suspended since July 8, 2026, following an incident involving a mix-up in embryo biopsy specimens from two patients.
The Council convened a special meeting on October 5, 2026, to review the clinic's license. Following a follow-up on-site inspection, the Council confirmed that Heal Fertility had properly implemented all necessary remedial and improvement measures. These measures included refining internal sample-handling procedures, strengthening staff training, and upgrading laboratory management and security systems. Enhancements to security systems include the installation of CCTV surveillance on the premises and biometric locks on all cryostorage tanks, along with improved sample identification and verification processes.
The Council also noted that the primary personnel involved in the incident had departed from Heal Fertility, and the clinic had recruited and trained new staff. The Department of Health will lift an order that had barred the clinic from taking new patients for assisted reproductive technology procedures.
The Council stated it will continue to closely monitor Heal Fertility's performance to ensure the provision of safe and high-quality services. Additionally, the Council has commenced a review of the Code of Practice on Reproductive Technology and Embryo Research, focusing on incident reporting mechanisms and the security and handling of biological samples, with a target completion date of next year.
Pick the topics you care about. Get only what matters, on your cadence.